7-phenyl-thieno[2,3-c]pyridine | 100067-45-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 7-phenyl-thieno[2,3-c]pyridine
• 英文别名: 7-Phenyl-thieno[2,3-c]pyridin；7-Phenylthieno[2,3-c]pyridine
• CAS: 100067-45-6
• 化学式: C₁₃H₉NS
• 分子量: 211.287
• InChiKey: GJCHHOJNYINUMF-UHFFFAOYSA-N

物化性质

• 沸点：
  150 °C(Press: 0.5 Torr)
• 密度：
  1.231±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  41.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  3-氨乙基噻吩 在 sodium hydroxide 、 palladium on activated charcoal 、 phosphorus pentoxide 、 xylene 、 三氯氧磷 作用下， 生成 7-phenyl-thieno[2,3-c]pyridine
  参考文献：
  名称：

  Sulfur Analogs of Isoquinolines

  摘要：

  DOI：

  10.1021/ja01145a117

文献信息

• Novel intramolecular diels-alder reactions with alkynylthio derivatives of 1,2,4-triazines. New routes to thieno[2,3-]pyridines and thieno[2,3-]pyridines.
  作者：Edward C. Taylor、John E. Macor

  DOI：10.1016/s0040-4039(00)94842-1

  日期：1985.1

  S-Alkylation of 1,2,4-triazine-6-thiones with 4-iodobutyne, followed by oxidation to the sulfoxide and intramolecular cycloaddition (at room temperature),gives 2,3-dihydrothieno[2,3-]pyridines, which are readily dehydrated with acetic anhydride to thieno[2,3-]pyridines. The same series of reactions carried out on 1,2,4-triazine-3-thiones leads to thieno[2,3-]pyridines.

  将1,2,4-三嗪-6-硫酮与4-碘丁炔进行S-烷基化，然后氧化成亚砜并进行分子内环加成（在室温下），得到2,3-二氢噻吩并[2,3- ]吡啶。容易用乙酸酐脱水成噻吩并[2,3- ]吡啶。在1,2,4-三嗪-3-硫酮上进行的相同系列反应导致噻吩并[2,3- ]吡啶。
• CYCLIC SULFONAMIDE CONTAINING DERIVATIVES AS INHIBITORS OF HEDGEHOG SIGNALING PATHWAY
  申请人：NANT HOLDINGS IP, LLC

  公开号：US20150299190A1

  公开（公告）日：2015-10-22

  The invention relates generally to the creation and use of cyclic sulfonamide containing derivatives to inhibit the hedgehog signaling pathway and to the use of those compounds for the treatment of hyperproliferative diseases and angiogenesis mediated diseases.

  本发明通常涉及使用含环磺酰胺基衍生物的创建和使用以抑制刺猬信号通路，并将这些化合物用于治疗高增殖性疾病和血管生成介导的疾病。
• ELECTROLUMINESCENT DEVICE
  申请人：BEIJING SUMMER SPROUT TECHNOLOGY CO., LTD.

  公开号：US20220402877A1

  公开（公告）日：2022-12-22

  Provided is an electroluminescent device. The electroluminescent device includes an anode, a cathode and an organic layer disposed between the anode and the cathode, where the organic layer includes at least a first compound having a structure of H-L-E and a second compound having a general formula of M(L a ) m (L b ) n (L c ) q . The novel material combination consisting of the first compound and the second compound can enable the electroluminescent device to obtain a lower voltage, higher efficiency and an ultra-long lifetime and can provide better device performance. Further provided are a display assembly and a compound combination.

  提供的是一种电致发光装置。该电致发光装置包括阳极、阴极和位于阳极和阴极之间的有机层，其中有机层包括至少一种具有H-L-E结构的第一化合物和具有M(La)m(Lb)n(Lc)q通式的第二化合物。该新型材料组合由第一化合物和第二化合物组成，可以使得电致发光装置获得更低的电压、更高的效率和超长的寿命，并提供更好的设备性能。另外还提供了一种显示组件和化合物组合。
• Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway
  申请人：NantBioScience, Inc.

  公开号：US10183013B2

  公开（公告）日：2019-01-22

  The invention relates generally to the creation and use of cyclic sulfonamide containing derivatives to inhibit the hedgehog signaling pathway and to the use of those compounds for the treatment of hyperproliferative diseases and angiogenesis mediated diseases.

  本发明一般涉及含有环磺酰胺的衍生物的创制和使用，以抑制刺猬信号通路，并将这些化合物用于治疗过度增殖性疾病和血管生成介导的疾病。
• Organic electroluminescent materials and devices
  申请人：UNIVERSAL DISPLAY CORPORATION

  公开号：US11325932B2

  公开（公告）日：2022-05-10

  A compound of Formula I or Formula II wherein Y is selected from the group consisting of O, S, and NRN; and (a) L1 and L2 are the same or different and are each a mono-anionic bidentate ligand; and R is selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; or (b) R joins with L1 of the Formulae I or II to form a ring B1 of formula B and formula C, respectively, and L2 is L3 and L3 is a tridentate ligand of formula D wherein ring C, ring D, and ring E are each independently selected from the group consisting a 5-membered aryl, a 5-membered heteroaryl, a 6-membered aryl, and a 6-membered heteroaryl; X1 to X4 are independently selected from C or N, and no more than two of the X1 to X4 is N; Z1 to Z7 are independently selected from C or N; wherein one of Z1, Z4, and Z7 is an anionic donor, and the remaining two are neutral donors; wherein Z2 and Z3 are not both N, and Z5 and Z6 are not both N; and the dotted lines represent coordination to the iridium; wherein each RA to RE represents mono to the maximum allowable substitution, or no substitution; and each RA to RE is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, wherein any two adjacent substituents RA to RE are optionally joined to form a fused ring.

  式 I 或式 II 的化合物 其中 Y 选自 O、S 和 NRN 所组成的组；以及 (a) L1 和 L2 相同或不同，且各自为单阴离子双齿配体；R 选自氢、氘、卤素、烷基、环烷基、杂环烷基、杂环烷基、芳烷基、烷氧基、芳氧基、氨基、硅烷基、烯基、环烯基、杂烯基、炔基、芳基、杂芳基、酰基、羧酸、醚、酯、腈、异腈、硫酰基、亚砜基、磺酰基、膦及其组合；或 (b) R 与式 I 或式 II 中的 L1 连接，分别形成式 B 和式 C 的环 B1，且 L2 是 L3，L3 是式 D 的三叉配体 在其中 环 C、环 D 和环 E 各自独立地选自由 5 元芳基、5 元杂芳基、6 元芳基和 6 元杂芳基组成的组； X1 至 X4 独立选自 C 或 N，且 X1 至 X4 中不超过两个为 N； Z1至Z7独立选自C或N；其中Z1、Z4和Z7中的一个是阴离子供体，其余两个是中性供体；其中Z2和Z3并非都是N，Z5和Z6并非都是N；虚线代表与铱的配位； 其中每个 RA 至 RE 表示单取代至最大允许取代量，或不取代；以及 每个 RA 至 RE 独立地为氢或选自以下组别的取代基：氘、卤素、烷基、环烷基、杂烷基、杂环烷基、芳烷基、烷氧基、芳氧基、氨基、硅烷基、烯基、环烯基、杂烯基、炔基、芳基、杂芳基、酰基、羧酸、醚、酯、杂环烷基、杂环炔基、杂环芳基、杂芳基、酰基、羧酸、醚、酯、硅烷基、炔基、芳基、杂芳基、酰基、羧酸基、醚基、酯基、腈基、异腈基、硫酰基、亚磺酰基、磺酰基、膦基及其组合，其中 RA 至 RE 的任意两个相邻取代基可选择连接形成一个融合环。